News & Alerts
-
Feb- 2024 -7 February
U.S. Department of Homeland Security (DHS) to Hire 50 AI Experts to Crack Down on Drugs, Child Abuse
The U.S. Department of Homeland Security (DHS) has announced plans to bolster its capabilities in combating a range of pressing…
Read More » -
5 February
New Study Says Zepbound May Significantly Lower Blood Pressure In Overweight Adults
In a groundbreaking study published on February 5, Eli Lilly’s revolutionary weight loss drug, Zepbound, has shown promising results in…
Read More » -
5 February
TING 1% Athlete’s Foot Spray Recalled Due to Elevated Benzene Levels
Insight Pharmaceuticals is recalling two lots of TING 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid due to elevated levels…
Read More » -
5 February
Novartis in Advanced Talks to Acquire MorphoSys: A Potential Game-Changer in Cancer Treatment
In a significant development, pharmaceutical giant Novartis AG is reportedly in advanced talks to acquire MorphoSys AG, a prominent developer…
Read More » -
2 February
FDA Warns Consumers of Contaminated Copycat Eye Drops: Urges Caution and Vigilance
In a public announcement on January 31, 2024, the U.S. Food and Drug Administration (FDA) issued a stern warning to…
Read More » -
Jan- 2024 -31 January
Global Biosurfactants Market Set to Hit $3.2 Billion By 2032 at 5.4% CAGR
Allied Market Research’s latest report indicates a promising future for the global biosurfactants market, citing stringent regulations on synthetic detergents…
Read More » -
31 January
Novo Nordisk Set to More Than Double U.S. Supply of Lower Wegovy Doses
Novo Nordisk, the Danish pharmaceutical company, is set to significantly increase the supply of lower doses of its obesity drug…
Read More » -
30 January
WHO Blames Rise in Reports of Fake Weight-Loss Drugs To Shortage of The Real Thing
In a recent statement, the World Health Organization (WHO) raised alarm about a surge in reports of counterfeit weight-loss drugs…
Read More » -
29 January
First Patient Enrolled in Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial
In a groundbreaking development, Rise Therapeutics, a pioneering clinical-stage biotechnology company, has enrolled its first patient in the Phase 1…
Read More » -
22 January
FDA Adds Boxed Warning for Prolia in Advanced CKD Due to Severe Risk Of Hypocalcemia
The U.S. Food and Drug Administration (FDA) has issued a Drug Safety Communication regarding Prolia (denosumab), an osteoporosis medication. Following…
Read More »